C M van Haelst-Pisani - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Mayo Clinic Proceedings|April 1, 1989

Cancer immunotherapy: current status of treatment with interleukin 2 and lymphokine-activated killer cellsC M van Haelst-Pisani, R J Pisani, J S Kovach

Cancer|December 1, 1991

Does histologic grade in soft tissue sarcoma influence response rate to systemic chemotherapy?C M van Haelst-Pisani, J C Buckner, H M Reiman, et al.

Cancer|November 1, 1992

A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancerC M van Haelst-Pisani, R L Richardson, J Su, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Mayo Clinic Proceedings|April 1, 1989

Cancer immunotherapy: current status of treatment with interleukin 2 and lymphokine-activated killer cellsC M van Haelst-Pisani, R J Pisani, J S Kovach

Cancer|December 1, 1991

Does histologic grade in soft tissue sarcoma influence response rate to systemic chemotherapy?C M van Haelst-Pisani, J C Buckner, H M Reiman, et al.

Cancer|November 1, 1992

A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancerC M van Haelst-Pisani, R L Richardson, J Su, et al.

Pageof 1